| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |